Neuroactive peptides and the intracellular calcium concentration ([Ca 2+ ] i were dependent, and the AVP effects independent of the action potential firing activity state of the neuron. We hypothesize that VIP and AVP regulate, at least in part, Ca 2+ homeostasis in SCN neurons and may be a major point of regulation for SCN neuronal synchronization.
Introduction
Several neuropeptides including VIP, AVP, PACAP, and OFQ have been shown to play important roles in the regulation of circadian clock function and entrainment (Piggins et al., 1996; Maywood et al., 2007; Miyakawa et al., 2007; Morin, 2007; Butler & Silver, 2009; Welsh et al., 2010) . Calcium is important in the signal transduction pathways mediating photic entrainment and an essential component of the feedback loops that generate circadian rhythms (Albrecht et al., 1997; Shearman et al., 1997; Shigeyoshi et al., 1997; Morris et al., 1998; . Yet currently little is known of the role that Ca 2+ plays in the neuropeptide regulation of the circadian clock.
The effect of neuropeptides on neuronal [Ca 2+ ] i , typically involve G-protein coupled receptors resulting in alterations of the membrane potential or second messenger-mediated release from intracellular stores (Maywood et al., 2006; Pakhotin et al., 2006; O'Neill et al., 2008) . Disruption of VIP signaling alters the action potential firing of SCN neurons, clock gene expression, behavioral circadian rhythms, and can be rescued by application of VIP or the VPAC2 receptor agonist RO 25-1553 Maywood et al., 2006; Pakhotin et al., 2006; Brown et al., 2007) . The role of Ca 2+ in VIP-mediated signaling in SCN neurons is currently unknown. Vasopressin is rhythmically released in the SCN with a peak during the day (Yamase et al., 1991; Tominaga et al., 1992; Nakamura et al., 2001) , which can be phase shifted by VIP (Watanabe et al., 2000) , and may play a role in the generation of circadian rhythms (Gouzenes et al., 1999; Kuhlman et al., 2003; Li et al., 2009) . Vasopressin agonists increase [Ca 2+ ] i in neurons of the supraoptic nucleus, an effect that was attenuated by IP 3 -receptor blockers and PLC and PKA inhibitors, suggesting that both phospholipase C and adenylate cyclase pathways are involved (Sabatier et al., 2004) . PACAP is localized with glutamate from RHT terminals (Hannibal et al., 2000; Hannibal et al., 2002) . PACAP application produces phase delays early in the night and phase advances late in the night similar to a light pulse (Harrington et al., 1999; Piggins et al., 2001) . PACAP potentiates the increased [Ca 2+ ] produced by AMPA, but not NMDA receptor activation in populations of SCN neurons (Kopp et al., 2001; Dziema & Obrietan, 2002) . Activation of OFQ receptors in the SCN reduces action potential firing, phase shifts the circadian clock, and down regulates mPER2 (Anton et al., 1996; Allen et al., 1999; Neal et al., 1999a; Teshima et al., 2005; Miyakawa et al., 2007) . OFQ decreases calcium and increases a potassium conductance in multiple brain regions including the SCN (Allen et al., 1999; Meis, 2003; Gompf et al., 2005) .
To clarify the role that Ca 2+ plays in the neuropeptide regulation within the SCN network, we recorded Ca 2+ from multiple neurons simultaneously examining the actions of VIP, AVP, PACAP, and OFQ on Ca 2+ signaling.
Methods

Tissue preparation
Hypothalamic slices were prepared, imaged and test agents applied using previously published methods (Irwin & Allen, 2009 ). Briefly, male Spraque-Dawley rats (Charles River, Wilmington MA) were housed for at least 1 week on a 12:12-hr light:dark schedule. During the light phase, 4 to 6 week old rats were anesthetized with isofluorane (Novaplus, UK), their brains removed, and coronal hypothalamic slices (250 μm) containing the SCN were cut with a vibrating blade microtome (Leica VT1000S, Nussloch, Germany), while the tissue was surrounded by ice-cold artificial cerebrospinal fluid (ACSF) containing (in mM): NaCl 120, KCl 2.5, NaH 2 PO 4 1.2, MgCl 2 5, CaCl 2 0.5, glucose 10, NaHCO 3 26, adjusted to 300 mOsm with sucrose and saturated with 5% CO 2 and 95% O 2 . The Institutional Animal Care and Use Committee of OHSU approved, in advance, all procedures involving animals.
Calcium Imaging
Multiple SCN neurons maintained in hypothalamic slices were loaded with the Ca 2+ -sensitive probe fura-2 AM for the simultaneous recording of Ca 2+ responses using previously published methods (Irwin & Allen, 2009 ). Briefly, freshly prepared SCN slices were treated with fura-2 AM (50 μM) for 1 -2 minutes (Invitrogen, CA; from stock 3.3 mM in DMSO) followed by incubation with fura-2 AM (10 -25 μM) in ACSF for 1-2 hours (Irwin & Allen, 2009 ). The slices were washed for at least 30 min prior to recording to allow for fura-2-AM deesterification and maintained in a recording chamber (35°C) with a continuous laminar flow (1 -2 ml/min) of an ACSF solution consisting of (in mM): NaCl 120, KCl 2.5, NaH 2 PO 4 1.2, MgCl 2 1.2, CaCl 2 2.4, glucose 10, HEPES 10, NaHCO 3 26; adjusted to 300 mOsm and bubbled with 5% CO 2 and 95% O 2 (Fig. 1) . Calcium measurements were obtained by recording a pair of images at excitation wavelengths of 340 and 380 nm supplied via a monochronometer (Polychrome IV; Till Photonics, Martinsried, Germany) passing through a UG11 optical filter to restrict harmonic wavelengths above 400 nM, reflected via a 400 nm DCLP dichroic mirror, and through a Leica 40x/0.80 UV water immersion objective. Emitted light passed through a 510 ± 40 nm filter (Chroma Technology Corp, Rockingham, VT) and was recorded with a cooled charge-coupled device camera (CCD, ORCA-ER 12 bit level, Hamamatsu, Japan) with acquisition time and binning adjusted to minimize photobleaching and maximize recording speed via the digital imaging software Metafluor (Molecular Devices Corporation, Sunnyvale, CA). Optical data was converted to relative fluorescence intensity units for each cell. Data was presented as the emission following excitation at 340 and 380 nm and background subtraction at each wavelength as previously described (Irwin & Allen, 2009 ). Neurons were identified by an increase in the Ca 2+ ratio in response to NMDA (200 μM for 5 sec). Cells that did not respond to NMDA or were dim were excluded. The Ca 2+ response (an increase, decrease or no effect) to VIP, AVP or OFQ was defined by a ratio change ≥2 standard deviations from the mean of 6 -11 baseline Ca 2+ ratios recorded prior to the peptide application. The magnitude of the Ca 2+ response to peptides having prolonged changes in Ca 2+ was determined from the mean of six Ca 2+ ratios at the apparent maximal response for each experiment. GABA, VIP(6-28) and PACAP produced transient neuronal Ca 2+ responses, and were coded as an increase, decrease or no response by visual inspection. The magnitude of the transient Ca 2+ response was determined as the maximum (or minimum for Ca 2+ decreases) response within the first 30 sec of application. The SCN neurons were localized to the dorsomedial (DM) and ventrolateral (VL) regions of the SCN as previously described (Irwin & Allen, 2009 ).
Chemicals
VIP, VIP(6-28), [Arg8]-Vasopressin, PACAP(1-38), GABA, and NMDA were obtained from Tocris Bioscience (Ellisville, MO). Fura-2 AM was purchased from Invitrogen (Carlsbad, California). Other chemicals were obtained from Sigma-Aldrich (St. Louis, MO).
Data and statistical analysis
Igor Pro (Version 6.0.4, Wavemetrics, Lake Oswego, OR, USA), Statview 5.0.1 (SAS Institute, Cary, NC, USA) and Excel 11.5.1 (Microsoft, Redmond, WA) were used for curve fitting and data analysis. Unless otherwise stated data are presented as the mean ± S.E.M. and t-tests (two tailed). A p level of ≤0.05 was used to determine statistical significance.
Results
VIP reduces Ca 2+ in SCN neurons during the day but not the night
The role of VIP in regulating Ca 2+ was examined by simultaneously imaging the mean Ca 2+ ratio of multiple neurons before and following VIP application during the day and night and at several locations within the SCN (Fig. 2) . During the day VIP (250 nM) reduced the Ca 2+ ratio [VIP(Ca−)] in 27% of neurons (ZT5-8 hours, n = 96), while VIP (1 μM) reduced the Ca 2+ ratio in 54% of neurons (ZT3-9 hours, n = 152 neurons). The proportion of neurons responding to 1 μM VIP was significantly greater than at 250 nM (z = 4.2, p < 0.0001). Regression analysis of the baseline Ca 2+ ratio in VIP(Ca−) neurons during the day plotted versus the change in the Ca 2+ ratio induced by VIP (1 μM), results in a slope of −0.50 ± 0.07 (R 2 = 0.41, n = 82, p < 0.0001) (Fig. 2C) , suggesting that neurons with higher Ca 2+ ratios and presumably faster action potentials firing frequencies, have a greater VIP-induced reduction of Ca 2+ than quiescent neurons with low Ca 2+ baseline ratios (Irwin & Allen, 2007; . In contrast, but consistent with this hypothesis, at night, VIP (1 μM) reduced the Ca 2+ ratio in only 7% of SCN neurons (ZT: 15-18 hours, n = 121 neurons) (Fig. 2A&B ). The few neurons observed at night with a VIP(Ca−) response had a higher mean baseline Ca 2+ ratio (1.30 ± 0.06, n = 8, Δ = −0.12 ± 0.04 ratio units) that differed significantly from the mean baseline Ca 2+ ratio in neurons that did not respond to VIP [VIP(Ca0)] (1.16 ± 0.03, n = 105, Δ0.001 ± 0.005; t 12 = 2.12, p = 0.028 one-tail with unequal variances). The Ca 2+ ratio in 64% of neurons was not altered by treatment with VIP (250 nM) during the day. Similarly, VIP (1 μM) did not change the Ca 2+ ratio of 39% of SCN neurons recorded during the day nor 87% during the night. VIP elevated the Ca 2+ ratio in a small subset of neurons during both the day (9% at 250 nM; 7% at 1 μM) and night (7% at 1 μM).
In SCN neurons, the mean baseline Ca 2+ ratio is higher during the day than the night (Colwell, 2000; Ikeda et al., 2003; Irwin & Allen, 2007; . During the day, VIP (1 μM) lowered Ca 2+ to near baseline nighttime levels ( Fig. 2A) . The reduction of the Ca 2+ ratio in VIP(Ca−) neurons during the day was larger at 1 μM than at 250 nM (0.35 ± 0.029 vs. 0.25 ± 0.038 ratio units respectively, t 106 = 1.75, p = 0.042 one-tail). These data demonstrate that while VIP can lower [Ca 2+ ] i during both the day and night a much greater proportion of VIP(Ca−) responding neurons were observed during the day when the mean baseline [Ca 2+ ] i is higher.
Localization of VIP-induced Ca 2+ response
We examined whether the VIP induced Ca 2+ changes differed regionally within the SCN during the day and night. The location of each VIP(Ca−) and VIP(Ca0) neuron was superimposed over a representative drawing of the SCN (Fig. 2D ). VIP(Ca−) responding neurons demonstrated no clear regional pattern.
VIP modulation of RHT signaling in the SCN network
Since VIP reduced the daytime baseline [Ca 2+ ] i , it may also play an important role in modulating light-responsive retinal ganglion cell signaling via the RHT to the SCN. Electrical stimulation of the RHT evokes divergent Ca 2+ responses in SCN neurons that were dependent on the action potential firing frequency and modulation by endogenous GABA A activity (Irwin & Allen, 2007; . Stimulation of the RHT via a bipolar electrode (100 pulses at 20 Hz) placed in the optic chiasm induced transient Ca 2+ elevations, reductions or no responses in the postsynaptic SCN neurons (Fig. 3A) . Application of VIP (1 μM) did not alter the magnitude of the Ca 2+ elevations induced by RHT stimulation during the day or the night.
During the day when [Ca 2+ ] i is generally high and neurons are rapidly firing, a RHTinduced reduction of [Ca 2+ ] i reflects an activation of GABAergic neurons and subsequent release of GABA; while at night when baseline [Ca 2+ ] i is low, a RHT-induced reduction of the [Ca 2+ ] i occurs in only a small number of neurons, suggesting that [Ca 2+ ] i cannot be reduced further (Irwin & Allen, 2009 ). Therefore, since VIP reduced the baseline Ca 2+ ratios during the day to near nighttime levels, the daytime RHT-evoked Ca 2+ reductions were also reduced (Fig. 3B) ; at night the baseline Ca 2+ ratios were generally low and VIP had little effect on RHT-evoked Ca 2+ reductions. These data suggest that, while VIP induces a reduction of [Ca 2+ ] i , it does not impair the ability of RHT input to elevate [Ca 2+ ] i in SCN neurons.
The role of GABA A receptor activation in the VIP-induced reduction of Ca 2+
VIP increases the frequency of GABA-mediated synaptic currents (Itri & Colwell, 2003; Itri et al., 2004) . Additionally, GABA A receptor activation can either raise or lower [Ca 2+ ] i in SCN neurons (Choi et al., 2008; Irwin & Allen, 2009 ). We therefore examined the relationship between VIP-and GABA-induced Ca 2+ responses in 122 SCN neurons. No association was observed between VIP responsive (VIP(Ca−), n = 71) and non-responsive (VIP(Ca0), n = 51) neurons, in relation to GABA-(200 μM, 10 sec) -evoked Ca 2+ ratio increases (GABA(Ca+), n = 47), decreases (GABA(Ca−), n = 45) or no responses (GABA(Ca0), n = 30; χ 2 = 0.23, p = 0.89). Since GABA A antagonists can alter baseline [Ca 2+ ] i (Irwin & Allen, 2009 ) and VIP(Ca−) responses are dependent on baseline [Ca 2+ ] i (Fig. 2C) , experiments with GABA A antagonists were not performed. These data suggest that the VIP-induced reduction of [Ca 2+ ] i is not mediated via GABA activity.
A VIP antagonist, VIP(6-28) modifies [Ca 2+ ] i in SCN neurons
Since VIP reduced [Ca 2+ ] i in SCN neurons during the day, we tested the hypothesis that endogenous VIP facilitates the [Ca 2+ ] i reduction observed during the night using the VIP antagonist VIP(6-28). Application of VIP(6-28) (2 -4 μM, ZT = 14 -18 hrs, n = 53) induced a variety of Ca 2+ responses in SCN neurons including transient and sustained elevations (41.5%), reductions (18.9%), and no responses (39.6%) (Fig. 4) . VIP(6-28) elevated the Ca 2+ ratio in the majority (~69%, n = 32) of responding neurons. Further, VIP(6-28) evoked larger Ca 2+ elevations than reductions (Fig. 4B) . During the day (ZT = 4-6 hrs, n = 33), the pattern of VIP(6-28) induced Ca 2+ responses was similar to that observed during the night (39.4% elevations, 12.1% reductions, 48.5% no response; χ 2 = 0.96, p = 0.62). The magnitude of the VIP(6-28) evoked Ca 2+ excursions were similar during the day and night (elevation day 0.31 ± 0.05, n = 13, night 0.30 ± 0.06, n = 22, t 33 = 0.11, p = 0.91; reduction day 0.11 ± 0.07, n = 4, night 0.15 ± 0.02, n = 10; t 12 = 0.74, p = 0.47) (Fig. 4B ). These data suggest that VIP may have a role in lowering [Ca 2+ ] i during the night.
AVP induces elevations of Ca 2+ during the day and night in SCN neurons
The effect of AVP on [Ca 2+ ] i of SCN neurons was evaluated with applications of AVP (1 μM) during the day and night (Fig. 5) . During the day, AVP elevated the Ca 2+ ratio [AVP(Ca+)] in 74%, generated no response [AVP(Ca0)] in 22% and lowered the Ca 2+ ratio [AVP(Ca−)] in 4% of SCN neurons (n = 72). Similarly, during the night the [Ca 2+ ] i was increased in 75% and generated no response in 25% of SCN neurons (n = 73). While the baseline Ca 2+ ratios of AVP(Ca+) neurons differed between the day (1.41 ± 0.05, n = 53) and night (1.11 ± 0.42, n = 55, t 104 = 4.78, p < 0.0001), the magnitudes of the Ca 2+ elevations were similar (day 0.28 ± 0.03, n = 53; night 0.31 ± 0.04, n = 55, t 106 = 0.54, p = 0.59). Further, blocking action potential firing with tetrodotoxin (TTX; 0.5 μM) did not block the AVP-induced Ca 2+ elevation (Fig. 5B) . The AVP-induced change in [Ca 2+ ] i was slow to develop with a mean time to peak (± SEM) of 27.0 ± 1.2 seconds.
While AVP induced [Ca 2+ ] i elevations during both day and night, VIP-induced [Ca 2+ ] i reductions almost exclusively during the day. There was however an association between responses to AVP and VIP (χ 2 = 17.5, n = 66, p < 0.0001) during the day in SCN neurons. In 41% of neurons where AVP induced a Ca 2+ ratio elevation (n = 51), VIP induced a Ca 2+ ratio reduction (n = 21). And 87% of neurons that did not respond to AVP during the day (n = 15) also did not respond to VIP (n = 13). The baseline Ca 2+ ratio of AVP(Ca+) responding neurons showed little correlation to the magnitude of the AVP-induced change in the Ca 2+ ratio during the day (R 2 = 0.03, n = 53, p = 0.24) or night (R 2 = 0.09, n = 55, p = 0.03). These data suggest that the Ca 2+ response to AVP was independent of the firing activity state of the SCN neuron, and that AVP(Ca+) sensitive neurons were more likely to be located in the dorsomedial region (Fig. 5C ).
The modulation of SCN neuronal [Ca 2+ ] i by PACAP
PACAP is thought to be co-released with glutamate from RHT terminals (Hannibal et al., 2000; Hannibal & Fahrenkrug, 2004) . PACAP(1-38) applied to SCN neurons during the day, activated a variety of transient changes in [Ca 2+ ] i without obvious alteration of RHT stimulation-induced transients (Fig. 6) . PACAP (250 nM) elevated the Ca 2+ ratio in 45.7%, reduced the Ca 2+ ratio in 10.6% and had no change of the Ca 2+ ratio in 43.6% of 94 neurons. PACAP (500 nM) induced similar (χ 2 = 2.12, p = 0.35) changes, with an elevation of Ca 2+ in 35.6%, a reduction in 16.9% and no-response in 47.5% of 59 neurons. Note that PACAP induced a response in only about 50% of neurons, and that reapplication often did not evoke subsequent Ca 2+ transients (data not shown). Consistent with previous studies (Kopp et al., 2001; Dziema & Obrietan, 2002; Michel et al., 2006) , these data suggest that PACAP acts to modulate the response of SCN neurons to input pathways.
The modulation of SCN neuronal [Ca 2+ ] i by OFQ
Orphanin-FQ (OFQ) (1 μM) produced the most dramatic and prolonged effect on the Ca 2+ ratio of SCN neurons during the day, reducing the Ca 2+ ratio in 83% of the neurons tested (n = 29; Fig. 7A ). In these neurons, the magnitude of the OFQ-induced reduction (−0.45 ± 0.08 ratio units) correlated linearly with the baseline Ca 2+ ratio (1.63 ± 0.09 ratio units, n = 24, slope = −0.83, R 2 = 0.82, p < 0.0001) (Fig. 7B) . Non-responding neurons already had lower baseline ratios (0.98 ± 0.13, n = 5). Unlike VIP, the OFQ effect was extremely long lasting and did not wash out during the remainder of the recording session. Five minutes after OFQ application, the Ca 2+ ratio remained low and even continued to slightly decline (−0.03 ± 0.01 ratio units, t = 2.84, p = 0.0094). These data demonstrated that OFQ induces a robust and prolonged reduction of [Ca 2+ ] i and suggests, that like VIP, this reduction is dependent on the action potential firing activity state of the SCN neuron.
Discussion
Neuroactive peptides are released from distinct neuronal populations and act on selective receptors to activate a variety of intracellular signaling pathways that ultimately may alter gene transcription (Maywood et al., 2006; Maywood et al., 2007; Pfeffer et al., 2009 (Colwell, 2000; Ikeda, 2004; Irwin & Allen, 2007; . We hypothesize that induction of Ca 2+ -mediated transcriptional and translational changes to the clock are dependent on the activity state of the neuron and its ability to rapidly alter [Ca 2+ ] i and are facilitated by neuropeptide modulation of both external and internal sources of Ca 2+ .
VIP has significant effects on the circadian clock and the activity of SCN neurons Pakhotin et al., 2006) . VIP acting on the VPAC2 receptor synchronizes the circadian clocks of individual SCN neurons . In smooth muscle, VIP has been thought to reduce Ca 2+ via membrane hyperpolarization, sequestration into intracellular stores, and activation of G-proteins (Ohta et al., 1991; Kawasaki et al., 1997) . VIP reduced the [Ca 2+ ] i in populations of SCN neurons during the day but has little effect at night. The day-night difference may reflect the action potential firing activity of SCN neurons at different parts of the circadian cycle. The magnitude of the Ca 2+ change was dependent on the baseline [Ca 2+ ] i , such that VIP (and OFQ) induced large reductions in Ca 2+ in neurons with high baseline [Ca 2+ ] i , as occurs in fast firing neurons, and had little or no effect on neurons with low baseline [Ca 2+ ] i , associated with low firing rates. Blocking action potentials with TTX similarly reduces [Ca 2+ ] i in more neurons during the day than the night (Colwell, 2000; Irwin & Allen, 2009 ). Our findings are consistent with the observation that VIP reduces the action potential firing of SCN neurons by inhibiting voltage-dependent Na + and K + channels (Pakhotin et al., 2006) . Since the firing activity of an SCN neuron contributes to the overall [Ca 2+ ] i (Irwin & Allen, 2007; , these data suggest that VIP alters the physiological action potential firing activity of the neuron to reduce the [Ca 2+ ] i .
A key question is whether VIP is contributing to the lower [Ca 2+ ] i and action potential firing rates observed during the night. VIP is released rhythmically in the SCN with higher levels at night than the day (Morin et al., 1993; Shinohara & Inouye, 1995; Nakamura et al., 2001; , and stimulated release of VIP in rat hypothalamus occurs only during the night (Nicholson et al., 1983) . We found that the VIP antagonist VIP(6-28) induced transient elevations of [Ca 2+ ] i in a proportion of SCN neurons during the night, suggesting a potential role for VIP activity in regulation of the SCN firing activity. However, while VIP(6-28) is frequently used as a VIP antagonist, it is only moderately effective even at large concentrations, may not be a competitive antagonist and may interact with other receptors (Markos et al., 2002) . While these data suggest that VIP may have a role in lowering the [Ca 2+ ] i of SCN neurons during the night, highly competitive antagonists are needed to confirm this mechanism.
While VIP expression is localized heavily in the ventral part of the SCN (Belenky et al., 2008) , we did not observe regional differences in the VIP-induced reductions in [Ca 2+ ] i . This is consistent with the wide distribution of VPAC2 expression, including about half of AVP-positive neurons (Kallo et al., 2004b) in the SCN, and consistent with a role of VIP in SCN synchronization. The SCN neurons with higher levels of [Ca 2+ ] i that did not respond to VIP, may represent neurons without VIP receptors, different VPAC2 receptor signaling pathways, quiescent neurons with high [Ca 2+ ] i due release from intracellular stores, or other mechanisms (Kallo et al., 2004b; Irwin & Allen, 2007; .
Since VIP reduces the excitability of SCN neurons, and VIP release, VIP mRNA, and VPAC2 expression are higher during the night (Albers et al., 1990; Rea, 1990; Morin et al., 1993; Shinohara et al., 1994; Shinohara et al., 1999) , an important question was whether light-induced glutamate release from RGC terminals in the SCN would be less likely to trigger the post-synaptic action potentials required to phase shift the clock. Stimulating the RHT, evokes divergent Ca 2+ responses in neurons within the SCN (Irwin & Allen, 2009 ). VIP did not alter the magnitude of RHT-evoked Ca 2+ elevations during either the day or night. These data suggest a model in which VIP reduces the firing of populations of SCN neurons, without altering the ability of the glutamatergic RHT input to elicit action potentials and elevate [Ca 2+ ] i . This may be important in the ability for light to induce phase changes during the night.
GABA-and VIP-expressing neurons in the SCN network are known to frequently interconnect and colocalize (Francois-Bellan et al., 1990; Francois-Bellan & Bosler, 1992; Buijs et al., 1995; Castel & Morris, 2000) . VIP regulates GABA release in the SCN and modulates SCN GABAergic signaling to subparaventricular zone neurons (Itri & Colwell, 2003; Itri et al., 2004; Hermes et al., 2009 (Choi et al., 2008; Irwin & Allen, 2009 ). We found no association between the VIP and GABA activity, and observed that VIP-induced reductions of Ca 2+ occurred in many neurons where GABA-induced an elevation (Fig. 3A) , suggesting that GABA does not mediate the VIP-induced reductions of [Ca 2+ ] i . V 1a and V 1b -type AVP receptors are expressed in the SCN and couple to G q -type G proteins, which activates phospholipase C activity and subsequently increases inositol-1,4,5 trisphosphate-induced Ca 2+ release from intracellular stores and diacylglycerol-mediated activation of protein kinase C (Majewski & Iannazzo, 1998; Birnbaumer, 2000) . While the rhythmic release of AVP by SCN neurons peaks during the day (Yamase et al., 1991; Tominaga et al., 1992) , the expression of V 1a -type receptor mRNA, but not the V 1b -type, peaks during the night (Young et al., 1993; Kalamatianos et al., 2004) . We found that AVP can induce elevations of [Ca 2+ ] i in the majority of SCN neurons during both the day and night. We observed a lag of approximately 30 sec from the onset of AVP application to the maximal response, suggesting that that the increased Ca 2+ was not a result of the rapid opening of voltage dependent Ca 2+ channels, but rather required second messengermediated process likely involving at least in part Ca 2+ release from intracellular stores. During the night AVP evoked similar elevations of Ca 2+ in the presence of TTX, further suggesting a mechanism of Ca 2+ release from intracellular stores. However, the closing of G protein-coupled inwardly-rectifying potassium channels inducing membrane depolarization may also make a contribution to the rise in [Ca 2+ ] i (Zhang et al., 2006) . In the supraoptic nucleus [Ca 2+ ] i is elevated by a V 1a -type AVP receptor agonist and attenuated by blocking IP 3 receptors. Similarly, Ca 2+ increases induced by V 1a -and V 2 -type, but not V 1b -type, AVP receptor agonists were attenuated by PLC and PKA inhibitors, suggesting that both phospholipase C and adenylate cyclase pathways are involved (Gouzenes et al., 1999; Sabatier et al., 2004) . This supports our observations that AVP elevates [Ca 2+ ] i in SCN neurons during both the day and night. Further, the regional location of AVP-sensitive SCN neurons appearing to overlap regions with known AVP immunoreactivity (Yamase et al., 1991; Moore et al., 2002) and the slightly higher dorsomedial expression of V 1a receptor mRNA (Young et al., 1993; Kalamatianos et al., 2004) suggest that AVP may be autoregulating its own release.
In addition to VIP and AVP, which appear to play key roles in generating and maintaining circadian timing, other neuropeptides modify the activity of the SCN (Teshima et al., 2005; Miyakawa et al., 2007) . While the application of PACAP and VIP produced different types of Ca 2+ responses, both peptides have been reported to have activity at the VPAC2 receptor while PACAP is more selective for the PAC1 receptor, and both receptors are expressed in the SCN (Ajpru et al., 2002; Kallo et al., 2004a; Yang et al., 2010) . PACAP's effect on [Ca 2+ ] i was variable with the Ca 2+ elevations tending to be transient and located more ventrolaterally, consistent with regions receiving greater RHT and PACAP associated input (Hannibal & Fahrenkrug, 2004) . The different responses observed using PACAP may be a consequence of PACAP modulating the activity of neurotransmission pathways (Kopp et al., 1999; Kopp et al., 2001; Dziema & Obrietan, 2002; Michel et al., 2006) . We found little or no change was observed in the Ca 2+ transients induced by RHT stimulation before and after application of PACAP. Previously, we have shown that RHT stimulation induces glutamate receptor-mediated excitatory postsynaptic potentials (EPSPs), but does not produce a change in somatic [Ca 2+ ] i without subsequently triggering an action potential and opening of voltage dependent Ca 2+ channels (Irwin & Allen, 2007 (Neal et al., 1999b) , the OFQ receptor mRNA is expressed along with high levels of radioligand binding (Anton et al., 1996; Neal et al., 1999a) . Further, OFQ can functionally alter circadian rhythms (Teshima et al., 2005; Leggett et al., 2007) . However, the anatomy of OFQ input to the SCN remains unclear. Several brain regions expressing OFQ mRNA also have neurons that project to the SCN including the raphe, the periaqueductal gray, and the lateral geniculate (Boom et al., 1999; Neal et al., 1999b; Hay-Schmidt et al., 2003; Horowitz et al., 2004) . We found OFQ application induced a sustained reduction of Ca 2+ that was strongly dependent (R 2 = 0.82) on the baseline [Ca 2+ ] i and consistent with prior observations (Allen et al., 1999; Ikeda et al., 2003) . Like VIP, OFQ appeared to quiet SCN neurons during the day with a reduction of the [Ca 2+ ] i to levels and variances more typical of neurons during the night (Irwin & Allen, 2009) , and this is consistent with a reduction in baseline action potential firing by OFQ in SCN neurons (Allen et al., 1999; Teshima et al., 2005) . While OFQ is known to reduce, it does not eliminate presynaptic glutamate release from RHT terminals (Gompf et al., 2005) 2+ ] i remain unclear, these data suggest that the activity state of the neuron, autoregulated at least in part by neuropeptides, may be a major point of regulation for SCN synchronization and modulation of light-input induced changes to the clock. 24, *** p < 0.0001), while most neurons had little or no response (VIP(Ca0), n = 61, t = 1.15, p = 0.25), and only 9 neurons had a Ca 2+ increase (data not shown). B. Comparison of the mean Ca 2+ ratio of SCN neurons at baseline and following application of VIP (1 μM) during the day (n = 152) and night (n = 121). During the day, VIP (1 μM significantly reduced the baseline Ca 2+ ratio (mean ± SEM) in VIP(Ca−) neurons (n = 82, t = 11.9, *** p < 0.0001), but not in the VIP(Ca0) group (n = 59, t = 1.71, p = 0.093), while only 11 neurons showed a Ca 2+ increase (data not shown). During the night, VIP reduced the Ca 2+ ratio in 7% of neurons. The data shown is the mean ± SEM of all nighttime neurons (n = 121 neurons, t = 0.114, p = 0.91). Note the baseline Ca 2+ ratios were higher during the day than the night, and that VIP reduced the Ca 2+ ratios of VIP(Ca−) responding neurons to near nighttime levels. C. Plot of the baseline Ca 2+ ratio versus the VIP (1 μM)-induced change in the Ca 2+ ratio in VIP(Ca−) neurons during the day. Note that larger reductions in Ca 2+ occur in neurons with higher baseline Ca 2+ ratios (R 2 = 0.41). D. Regional location of VIP-treated neurons during the day and night. The position for each VIP(Ca−) and VIP(Ca0) neuron was superimposed on a representative drawing of the SCN with the third ventricle (3V) on the left and optic chiasm (OC) at the bottom. Neither VIP(Ca−) or VIP(Ca0) neurons demonstrated a clear regional expression pattern. A. The postsynaptic Ca 2+ ratio in two SCN neurons with similar reductions in response to VIP (1 μM), but opposing responses to both GABA (200 μM, 10 sec) and stimulation of the RHT (arrows, 100 pulses, 200 μs at 20 Hz). B. VIP (1 μM) had little or no effect on RHTevoked elevations of Ca 2+ (top) during the day (n = 36 neurons, t = 0.43, p = 0.67) and night (n = 22, t = 0.39, p = 0.70), but attenuated RHT-evoked Ca 2+ reductions during the day (n = 10, t = 2.82, ** p < 0.020), but not the night (n = 3, t = 1.06, p = 0.40). Data is the mean ± SEM of maximum (Ca 2+ elevations) and minimum (Ca 2+ reductions) responses to RHTevoked changes in the Ca 2+ ratio before and during VIP (1 μM) application. Note that since VIP reduced the baseline Ca 2+ , the magnitudes of RHT-evoked Ca 2+ reductions were also reduced, while at night the baseline Ca 2+ ratio was low with few RHT-evoked Ca 2+ transient reductions. 
